Evidence map›Paper›PMID 36793652›Full record

ArticleActa myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology2022

Is paravertebral muscles edema a consequence of neurogenic changes in MuSK-positive myasthenia gravis?

Sergey N Bardakov, Vadim A Tsargush, Pierre G Carlier, Tran Minh Duc, Andrey Yu Emelin, Alexey Yu Polushin, Alexander A Emelyantsev, Andrey N Belskikh, Ekaterina N Berezhnaya, Sergey V Lapin and 2 more

Open access · greenAbstract read
In one paragraph

Article in Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 71% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Sergey N BardakovS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Vadim A TsargushS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Pierre G CarlierCEA, Frédéric Joliot Institute for Life Sciences, SHFJ, Orsay, France.
Tran Minh DucS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Andrey Yu EmelinS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Alexey Yu PolushinPavlov First Saint Petersburg State Medical University, St. Petersburg, Russia.
Alexander A EmelyantsevS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Andrey N BelskikhS.M. Kirov Military Medical Academy, St. Petersburg, Russia.
Ekaterina N BerezhnayaI.I. Mechnikov North-Western State Medical University, Saint Petersburg, Russia.
Sergey V LapinPavlov First Saint Petersburg State Medical University, St. Petersburg, Russia.
Anna N MoshnikovaPavlov First Saint Petersburg State Medical University, St. Petersburg, Russia.
Roman V Deev
S. M. Kirov Military Medical Academy · RUFirst Pavlov State Medical University of St. Petersburg · RUNorth-Western State Medical University named after I.I. Mechnikov · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anti-MuSK myasthenia gravis (Anti-MuSK MG) is a chronic autoimmune disease caused by complement-independent dysfunction of the agrin-MuSK-Lrp4 complex, accompanied by the development of the pathological muscle fatigue and sometimes muscle atrophy. Fatty replacement of the tongue, mimic, masticatory and paravertebral muscles, revealed by muscle MRI and proton magnetic resonance spectroscopy (MRS), is considered to be a consequence of the myogenic process in anti-MuSK antibody MG in the patients with a plenty long course of the disease. However, in most experimental studies on animal models with anti-MuSK MG, complex presynaptic and postsynaptic changes are revealed, accompanied by the functional denervation of masticatory and paravertebral muscles predominantly. This study presents the MRI, nerve conduction studies (NCS), repetitive nerve stimulation (RNS) and electromyography (EMG) of neurogenic lesions of the axial muscles (m. Multifidus Th12, L3-L5; m. Erector spinae L4-L5) in two patients K. (51 years old), and P. (44 years old), both of whom were having weakness of the paravertebral muscles for 2-4 months due to anti-MuSK MG. The clinical manifestations, as well as the edematous changes in the paravertebral muscles, regressed after therapy. Thus, these clinical examples may confirm the presence of the neurogenic changes at an early stage of anti-MuSK myasthenia gravis and indicate importance of immediate initiation of therapy to avoid the development of muscle atrophy and fatty infiltration.

Indexed as

Myasthenia GravisReceptors, CholinergicAnimalsElectromyographyHumansMusclesMuscular AtrophyReceptor Protein-Tyrosine KinasesMUSK protein, humanReceptor Protein-Tyrosine KinasesReceptors, Cholinergicantibodies to MuSKanti-MuSK myasthenia gravismuscle MRIneurogenic muscle edema

Identifiers

PMID36793652
PMCPMC9896596
OpenAlexW4321002250

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.